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LosartanA high salt diet is associatedwith reduced activity of the renin–angiotensin–aldosterone system (RAAS). Howev-
er, normotensive rats exposed to high sodium do not show changes in systemic arterial pressure. We hypothe-
sized that, despite the reduced circulating amounts of angiotensin II induced by a high salt diet, the
cardiovascular system's reactivity to angiotensin II is increased in vivo, contributing to maintain arterial pressure
at normal levels. MaleWistar rats received chow containing 0.27% (control), 2%, 4%, or 8% NaCl for six weeks. The
high-sodium diet did not lead to changes in arterial pressure, although plasma levels of angiotensin II and aldo-
sterone were reduced in the 4% and 8% NaCl groups. The 4% and 8% NaCl groups showed enhanced pressor re-
sponses to angiotensin I and II, accompanied by unchanged and increased angiotensin-converting enzyme
activity, respectively. The 4% NaCl group showed increased expression of angiotensin II type 1 receptors and re-
duced expression of angiotensin II type 2 receptors in the aorta. In addition, the hypotensive effect of losartanwas
reduced in both 4% and 8% NaCl groups. In conclusion these results explain, at least in part, why the systemic ar-
terial pressure is maintained at normal levels in non-salt sensitive and healthy rats exposed to a high salt diet,
when the functionality of RAAS appears to be blunted, as well as suggest that angiotensin II has a crucial role
in the vascular dysfunction associated with high salt intake, even in the absence of hypertension.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
The effects of sodium intake on the functionality of the renin–
angiotensin–aldosterone system (RAAS) have been widely investigated
in the past decades, revealing that sodium restriction in healthy animals
results in increased angiotensin II levels in plasma, accompanied by
reduced vascular reactivity, while excessive ingestion of sodium leads
to decreased production of angiotensin II but augmented stimulatory
effects of this mediator in vitro [2,6,42]. Despite the recent studies
addressing this ﬁeld, the physiology, functionality and importance of
the RAAS for the effects of high salt intake on the cardiovascular system
of healthy subjects remain poorly understood, mainly because the vast
majority of these studies were performed in Dahl salt-sensitive,ne system; ACE, angiotensin-
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rats. In these animal models, high salt intake has been often associated
with reduced activity or circulating levels of renin, angiotensinogen,
angiotensin-converting enzyme (ACE), angiotensin II, or aldosterone
[4,16,24]. Nevertheless, these same studies revealed that the high salt
diet increased angiotensin II and aldosterone in kidney and heart of
Dahl salt-sensitive [4], as well as the plasma levels of angiotensinogen
and angiotensin II in spontaneously hypertensive rats [16]. Interesting-
ly, Kobori and co-workers found that exposure to a high salt diet
reduced plasma renin and angiotensinogen in both Dahl salt-sensitive
and Dahl salt-resistant rats, but only Dahl salt-sensitive rats presented
increased levels of angiotensinogen in kidneys and urine [24]. All
together, these studies suggest that in salt-sensitive and spontaneously
hypertensive rats, the excessive ingestion of saltmay result in increased
production or activation of components of RAAS in tissues, such as kid-
neys, in spite of their reduced levels in plasma. Indeed, it suggests that
angiotensin II plays a role in the vascular dysfunction associated with
high salt ingestion in experimental models of hypertension. However,
the effects of high salt intake in the in vivo functionality of RAAS in
non-hypertensive and healthy animals remain unclear.
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intake increases both the mRNA levels and protein expression of
angiotensin II type 1 (AT1) receptors in the aorta and vascular smooth
muscle cells [30], and reduces the expression of angiotensin II type 2
(AT2) receptors in small mesenteric arteries [13] of normotensive
Sprague–Dawley rats. However, none of the previous studies investigat-
ed the impact of high salt-induced changes in the RAAS on the systemic
pressor effects of angiotensin II. We hypothesized that, in spite of
the reduced circulating amounts of angiotensin II induced by a high
salt diet, the cardiovascular system becomes more responsive to the
renin–angiotensin system, improving its ability to convert angiotensin
I to angiotensin II and increasing the reactivity to angiotensin II in vivo.
This modulation at multiple levels could explain why the arterial
pressure of healthy animals exposed to excessive amounts of salt is
not impaired, even when the total circulating amounts of angiotensin
II in plasma are greatly reduced.
2. Material and methods
2.1. Animals and experimental protocols
All procedures adopted in this studywere approvedby the Institution-
al Ethics Committee for Animal Use of theUniversidade Federal do Paraná
(authorization number 345), andby the Institutional Animal Care andUse
Committee of Georgia Health Sciences University (authorization number
2011-0353). We used male Wistar rats provided by either Universidade
Federal do Paraná (Curitiba, PR, Brazil) or Harlan Laboratories
(Indianapolis, IN, USA). The animalswere kept under standard laboratory
conditions, with a constant 12-hour light/dark cycle and controlled tem-
perature (22 ± 2 °C). Both water and foodwere supplied ad libitum. The
study included four distinct experimental groups. The ﬁrst group, used as
control, received standard rat chow (purchased from Nuvital®, Curitiba,
PR, Brazil or Teklad Global Diets®, Indianapolis, IN, USA), containing the
regular amount of NaCl (0.27%). The other three groups received rat
chow containing 2%, 4%, or 8% NaCl. This exposure to high amounts of
NaCl was started at weaning and continued for six weeks, when the ex-
periments were performed.
2.2. Evaluation of cardiovascular reactivity in anesthetized rats
At the end of the sixthweek, the rats were anesthetized by intramus-
cular injection of ketamine and xylazine (100/20 mg/kg), and surgically
prepared for direct blood pressure measurement, as previously de-
scribed [9]. The mean arterial pressure (MAP) was assessed through a
catheter inserted into the carotid artery, and connected to a pressure
transducer coupled to a digital recording system (MacLab®) and its soft-
ware (Chart, v 4.0), both from AD Instruments (Castle Hill, Australia).
After the surgical process, there was an interval of 20 min to allow for
blood pressure stabilization before the injection of any drug.
After stabilization, different animals received intravenous injections
containing either angiotensin I (3, 10 and 30 pmol/kg), angiotensin II
(3, 10 and 30 pmol/kg), or bradykinin (3, 10 and 30 nmol/kg). The
doses were injected in a total volume of 250 μL (including washing of
the catheter). An interval of 10 min was allowed for MAP stabilization
between each administration. The maximal effect on MAP (in mm Hg)
and the duration of responses (in s) were calculated and compared
among the groups.
In a separated series of experiments, the effects of angiotensin II on
MAP were evaluated before and 5 min after a single administration of
losartan (1 mg/kg, given as intravenous bolus injection), a selective an-
giotensin II AT1 receptor antagonist. The ability of losartan to reduce the
pressor effects of angiotensin II in control and 4% NaCl groups was eval-
uated in this approach. In addition, the hypotensive effects of losartan
(3, 10, and 30 mg/kg) were evaluated in all experimental groups.
The animals were killed with an overdose of thiopental (over
40 mg/kg, administered by intravenous injection). In some experiments,the thoracic aorta was removed and quickly frozen in liquid nitrogen for
subsequent Western blot analysis.
2.3. Measurement of systolic blood pressure in conscious rats
To verify if the absence of hypertension in animals subjected to a
high salt diet in our experiments could be related to the anesthetic
drugs used, systolic blood pressure was measured in conscious rats at
2, 3, 4, 5 and 6 weeks of exposure to regular (control) or 4% NaCl
chow. These experiments were performed using a non-invasive volume
pressure recording sensor that was placed around the tail, allowing the
measurement of arterial pressure parameters in a digital recording
system (CODA System, Kent Scientiﬁc, Torrington, CT, USA).
2.4. Measurement of diuresis
In order to evaluate the inﬂuence of a high salt diet on diuresis and
natriuresis, rats exposed to diets containing 2%, 4% and 8% NaCl
(as well as animals belonging to the control group) were individually
accommodated in metabolic cages for 8 h (with free access to water),
allowing the continuous measurement of urinary output. To avoid the
inﬂuence of hormones endogenously released at different times of the
day, these experiments were always performed from 8 AM to 4 PM. In
addition, the urine collected was checked for density, pH, and sodium
concentration [22]. These experiments were performed once a week
during the exposure to a high salt diet.
2.5. Biochemical assays
2.5.1. ACE assay
At the end of six weeks of receiving the high salt diet, blood samples
were collected from animals that had not been subjected to pharmaco-
logical manipulation. The blood was centrifuged (800 g for 15 min) for
plasma separation. The plasma samples were kept at−80 °C until the
assayswere performed. For the ACE assay, 10 μL of plasmawas incubated
with 490 μL of the assay solution (composition: Hip-His-Leu at 5 mM in
0.4 M sodium borate buffer, pH 8.3) for 15 min at 37 °C. The reaction
was stopped by addition of 1.2 mL of NaOH (0.34 N). The product,
His-Leu, was measured ﬂuorometrically (365 nm excitation and
495 nm emission, Aminco Model J4-7461 ﬂuoromonitor, American
Instrument Co., Silver Spring, MD, USA) after the addition of 100 μL of
o-phthaldialdehyde (20 mg/mL) in methanol for 10 min, followed by
200 μL of HCl (3 N) and centrifugation at 800 g for 5 min at room
temperature [37]. To correct for the intrinsic ﬂuorescence of plasma,
time-zero blank samples were prepared by adding plasma after NaOH
treatment. All measurements were made in triplicate.
2.5.2. Angiotensin II and aldosterone assays
For these experiments, blood samples from the control, 4% and 8%
NaCl groups (without any pharmacological manipulation) were collected
immediately after the induction of anesthesia by oxygen–isoﬂurane (3%)
inhalation. The bloodwas put into glass tubes containing 7.5% ethylenedi-
aminetetraacetic acid (EDTA), and centrifuged for plasma separation
(800 g for 15 min). Angiotensin II levels in the plasma were measured
by enzyme immunoassay immediately after methanol extraction, as
previously described [40]. The concentration of aldosterone in the plas-
ma was measured by enzyme-linked immunosorbent assay (ELISA;
Immuno-Biological Laboratories, Inc., Minneapolis,MN, USA), according
to the manufacturer's instructions. All measurements were made in
duplicate.
2.5.3. Detection of angiotensin II receptors by Western blotting
The expression levels of AT1 and AT2 receptors were evaluated in
thoracic aortas obtained from the control and 4% NaCl groups. After
removal from the animal, the entire thoracic aorta was quickly frozen
in liquid nitrogen and maintained at−80 °C until it was processed for
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40 μg of protein per well in 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) run in theMini-PROTEAN® Tetra cell ap-
paratus connected to a PowerPac™HC power supply (both fromBio-Rad,
CA, USA). Protein quantiﬁcation and electrophoresis followed the same
protocol and the same reagents were used as previously described [46].
The proteins were electrophoretically transferred to nitrocellulose mem-
branes (Hybond; AmershamBiosciences, NJ, USA), and subjected to poly-
clonal anti-AT1 and anti-AT2 receptors (Santa Cruz Biotechnology, Dallas,
TX, USA), or monoclonal anti-actin (Sigma-Aldrich, St. Louis, MO, USA)
primary antibodies overnight at 4 °C, followed by a horseradish peroxi-
dase (HRP)-conjugated secondary antibody for 1 h at room temperature.
The membranes were washed and exposed to chemiluminescent sub-
strate for HRP (Pierce Biotechnology, Rockford, IL, USA) for protein detec-
tion using a FluorChem® HD2 Imaging System (Alpha Innotech Corp.,
Santa Clara, CA, USA). The bands were quantiﬁed by densitometry using
UN-SCAN-IT gel software (Silk Scientiﬁc, Inc., Orem, UT, USA).2.6. Drugs and reagents
Angiotensin I, angiotensin II, bradykinin, o-phthaldialdehyde and
hippuryl-L-histidyl-L-leucine were obtained from Sigma (St. Louis, MO,
USA). Losartan was donated by Bula Verdde Pharmacy (Curitiba, PR,
Brazil). The angiotensin II measurement kit was purchased from
Cayman Chemical Company (Ann Arbor, MI, USA). Antibodies against
angiotensin I and II receptors were produced by Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Bradykinin, angiotensin I, and angio-
tensin II (stock solutions) were dissolved in HCl (0.1 N), and diluted in
regular isotonic saline solution (0.9% NaCl) immediately before each
experiment.2.7. Statistical analysis
The results are expressed as mean ± standard error of the mean
(SEM) of ﬁve to eight experiments per group. The data were analyzed
by one- or two-way analysis of variance (ANOVA) with Bonferroni's
post hoc test, or Student's t test, when applicable. A value of P b 0.05
was considered statistically signiﬁcant. Graphswere drawn and statisti-
cal analyses were performed using GraphPad Prism version 5.01 for
Windows (GraphPad Software, San Diego, CA, USA).3. Results
3.1. Enhanced responsiveness to angiotensin I and activity of ACE after high
salt intake
Administration of angiotensin I led to dose-dependent pressor
effects in the 2% NaCl group that did not differ from control, but signiﬁ-
cantly enhanced pressor effects were observed in the 4% and 8% NaCl
groups (Fig. 1). For instance, with the intermediate dose of angiotensin
I used in our experiments (10 pmol/kg), MAP was increased by
53.1 ± 5.8 and 55.5 ± 5.8 mm Hg in the 4% and 8% NaCl groups,
respectively, and by 29.5 ± 2.8 mm Hg in the control group (P b 0.05,
comparing the control group with the 4% and 8% NaCl groups).
Quantitative analysis of ACE activity revealed a signiﬁcant increase
(approximately 20%) in plasma samples obtained from the 8% NaCl
group compared with control, but there was no increase in samples ob-
tained from the 2% and 4%NaCl groups (Fig. 2a). This ex vivo activitywas
functionally conﬁrmed in vivo by a reduced duration in the hypotensive
effect of bradykinin in rats from the 8% NaCl group (Fig. 2b), with no
change in the peak of hypotensive responses (data not shown). Animals
from the 2% and 4% NaCl groups did not show impaired responses to
bradykinin (data not shown).3.2. Increased effects of angiotensin II after high salt intake
Although the rats exposed to chow containing 2% NaCl did not show
altered responses to angiotensin II (Fig. 3a), increased reactivity to this
peptide was found in animals from the 4% and 8% NaCl groups. For
instance, the pressor effects of the intermediate dose of angiotensin II
tested in our experiments (10 pmol/kg) were signiﬁcantly increased
from 39.5 ± 4.7 (control) to 54.6 ± 5.7 and 63.3 ± 6.0 mm Hg in the
4% and 8% NaCl groups, respectively (Fig. 3b and c). In addition, the
duration of the effects of 3, 10 and30 pmol/kg angiotensin IIwas extend-
ed, respectively, from 94.9 ± 17.2, 152.2 ± 19.1, and 189.5 ± 22.0 s in
the control group, to 451.1 ± 82.8, 579.5 ± 55.2, and 628.9 ± 114.7 s
in the 8% NaCl group (P b 0.05, for all doses tested).3.3. Unaltered arterial pressure in normotensive rats exposed to a high
salt diet
In spite of the observed enhanced effects of angiotensin I and II,
animals subjected to 2%, 4% or 8% NaCl from weaning for six weeks
did not show any change in heart rate or arterial pressure, as measured
in anesthetized rats before the administration of vasoactive drugs
(Table 1). Similarly, systolic arterial pressure measured in conscious
animals did not differ between the 4% NaCl and control groups
(Fig. 4).3.4. Reduced levels of circulating angiotensin II and aldosterone and
increased diuresis after high salt intake
Levels of angiotensin II and aldosterone were reduced in the plasma
samples of animals exposed to chow containing 4% and 8%NaCl. Plasma
levels of angiotensin II (89.3 ± 21.4 pg/mL in the control group) were
reduced by 70 to 80% in the 4% and 8% NaCl groups (Fig. 5a). Likewise,
aldosterone levels (16.4 ± 4.0 ng/mL in the control group) were
reduced by 80 and 60% in the 4% and 8% NaCl groups, respectively
(Fig. 5b). In accordance with the reduced plasma levels of aldosterone,
rats exposed to a high salt diet (the 4% and 8% NaCl groups) showed a
signiﬁcant increase in urinary output (30 to 150%) in all weeks of treat-
ment (Fig. 6a). Similarly, urinary excretion of sodium was signiﬁcantly
increased (Fig. 6b). The density and pH of urine were unchanged at all
analyzed time points (data not shown).3.5. Altered expression of AT1 and AT2 receptors and effects of losartan after
high salt intake
As revealed by Western blot analyses, the aorta of rats exposed to
chow containing 4%NaCl showed increased expression of AT1 receptors
compared with control (Fig. 7a). On the other hand, the expression of
AT2 receptors was reduced in the 4% NaCl group (Fig. 7b).
Administration of AT1 receptor antagonist losartan (1 mg/kg, i.v.)
signiﬁcantly reduced the effects of all doses of angiotensin II in control
animals (Fig. 7c, black bars), but it failed to inhibit the pressor effects
induced by the higher doses of angiotensin II (10 and 30 pmol/kg) in
the 4% NaCl group (Fig. 7c, white bars). Importantly, this small dose of
losartan did not change the basal systemic arterial pressure in any of
our experimental groups. However, the intravenous injection of 3, 10
and 30 mg/kg of losartan reduced the MAP of control animals by
9.6 ± 1.3, 12.5 ± 1.1 and 21.3 ± 2.6 mm Hg, respectively. Interesting-
ly, both 3 mg/kg (Fig. 7d) and 10 mg/kg (data not show) presented
reduced effects in animals from4% and 8%NaCl groups. However, the hy-
potensive effect obtained after administration of losartan at 30 mg/kg
did not differ between the control and NaCl groups (21.3 ± 2.6,
27.9 ± 4.8, 29.1 ± 5.3 and 11.9 ± 6.6 mm Hg, for control and 2%, 4%,
and 8% NaCl groups, respectively).
Fig. 1. Enhanced pressor effects of angiotensin I in normotensive rats exposed to a high-sodiumdiet for sixweeks. Increase inmean arterial pressure (a, c and e) andduration of the pressor
effect (b, d and f) of intravenously administered angiotensin I (3, 10 and 30 pmol/kg). Angiotensin Iwas administered in bolus in anesthetized rats previously subjected to highNaCl (2, 4 or
8%) chow. The results shown aremean ± SEM (n = 6–7). Statistical analyseswere performed by two-way analysis of variance followed by Bonferroni's post hoc test. *P b 0.05 compared
with the respective control group.
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In this study, using normotensive and healthyWistar rats, we found
that animals fed chow containing 4% and 8% NaCl displayed augmented
pressor responses to intravenously administered angiotensin I and
angiotensin II. Both the peak of the responses and the duration of the
effects were signiﬁcantly increased. Studies, performed mainly in
salt-sensitive and hypertensive rats, have suggested that RAAS is
inhibited by high salt intake, as evidenced by reduced activity or
levels of renin, angiotensinogen, ACE, angiotensin II and aldosterone
in the plasma of these animals [4,16,24,33], although augmented tissue
levels of angiotensinogen, angiotensin II and aldosterone have been
found mainly in kidneys [4,24]. These studies indicate that local activa-
tion of components of RAAS may be involved in the vascular dysfunc-
tion and maintenance of hypertension in experimental models of
hypertension associated with a high salt diet, in spite of the reduced
systemic activation of RAAS. However, the in vivo functionality of
RAAS in normotensive animals fed a high salt diet remains poorly un-
derstood. Indeed, at least to our knowledge, this is the ﬁrst study
using in vivo approaches to demonstrate that in spite of the reduced
levels of circulating angiotensin II, animals subjected to a high salt diet
present increased pressor responses to angiotensin II and reduced hy-
potensive effects mediated by losartan, both associated with augment-
ed expression of angiotensin II AT1 receptors.Using blood samples collected from anesthetized rats, a strategy that
may have increased the levels of angiotensin II found in the plasma of
high salt animals (as well as in control group) [7,19], we did conﬁrm
that both angiotensin II and aldosterone were reduced in the plasma of
Wistar rats after six weeks under high salt intake (Fig. 5). Nevertheless,
our study also demonstrates that in spite of these ﬁndings, the capacity
of angiotensin II to increase systemic arterial pressure is maintained or
even increased in healthy rats subjected to a high salt diet.
The enhanced reactivity to angiotensin II has been described in sev-
eral in vitro studies and has been associatedwith augmented expression
of AT1 receptors [30] or reduced expression of AT2 receptors [2,34,36],
which mediate angiotensin II-induced vasodilation [41]. For compara-
tive purposes, we also evaluated the expression levels of both AT1 and
AT2 receptors in vessels removed from rats subjected to high salt intake.
The results conﬁrmed the ﬁndings of previous studies, demonstrating
increased expression of AT1 receptors and a simultaneous reduction in
the levels of AT2 receptors (Fig. 7). In order to better explore the role
of augmented expression of AT1 receptors in the increased reactivity
to angiotensin II found after the high-sodium diet in our in vivo experi-
ments, we evaluated the effects of a single dose of losartan, a selective
AT1 receptor antagonist, against the pressor effect of angiotensin II in
both control and 4% NaCl group. Losartan similarly inhibited the effects
of the smallest dose of angiotensin II in both control and 4%NaCl groups,
but failed to reduce the effects of the highest doses of angiotensin II in
Fig. 2. Increased plasma angiotensin-converting enzyme (ACE) activity and reduced dura-
tion of the hypotensive effect of bradykinin in normotensive rats fed with 8% NaCl chow.
Plasma ACE activity (a) was measured in samples collected from the 2%, 4% and 8% NaCl
groups. The letter ‘C’ indicates the control group. The duration of the hypotensive effect
of bradykinin after its intravenous administration in anesthetized rats (b). The results
shown are mean ± SEM (n = 5–12). Statistical analyses were performed by one-way
(a) or two-way analysis of variance (b), followed by Bonferroni's post hoc test. *P b 0.05
compared with the respective control group.
Fig. 3. Augmented pressor responses to angiotensin II in normotensive rats exposed to a
high-sodium diet for six weeks. Increase inmean arterial pressure induced by angiotensin
II (administered in bolus) in rats fromthe 2% (a), 4% (b), and 8% (c)NaCl groups. The effects
weremeasured in anesthetized rats after sixweeks of exposure to a high-sodiumdiet. The
results shown are mean ± SEM (n = 5–6). Statistical analyses were performed by two-
way analysis of variance followed by Bonferroni's post hoc test. *P b 0.05 compared
with the control group.
Table 1
Arterial pressure and heart rate of anesthetized rats exposed to high sodium intake for six
weeks from weaning.
Group SAP (mm Hg) DAP (mm Hg) MAP (mm Hg) HR (bpma)
Control 101.3 ± 4.0 68.4 ± 4.8 82.4 ± 4.2 227.1 ± 21.7
2% NaCl 94.8 ± 3.9 58.5 ± 3.9 73.6 ± 3.5 203.7 ± 15.5
4% NaCl 101.9 ± 1.9 63.2 ± 3.5 78.3 ± 2.6 220.4 ± 10.7
8% NaCl 107.2 ± 3.4 63.5 ± 5.0 80.5 ± 4.6 202.0 ± 18.3
The results shown are mean ± SEM (n = 6–7). Systolic arterial pressure (SAP), diastolic
arterial pressure (DAP), mean arterial pressure (MAP), and heart rate (HR). No statistical
differences were found.
a bpm: Beats per minute.
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induce hypotension in both control and NaCl groups. For this purpose,
the animals received bolus intravenous injection of losartan at 3, 10 or
30 mg/kg. Interestingly, the smallest dose of losartanwas able to induce
a transitory hypotensive effect in control and 2% NaCl groups, which
was almost abolished in 4% and 8% NaCl groups (Fig. 7d). A similar
proﬁle of effect was observed even when the intermediary dose
(10 mg/kg) of losartan was tested (data not shown). On the other
hand, the highest dose (30 mg/kg) was able to induce hypotension in
both control andNaCl groups (see Results section for details), indicating
that although less sensitive to losartan, the AT1 receptors present in the
vascular system of rats fed a high salt diet remain fully functional and
under inﬂuence of endogenous angiotensin II, in spite of the reduced
plasma levels of angiotensin II found in these animals. Taken together,
these data suggest that the enhanced effects of angiotensin II found
in vivo after high salt intake are, at least in part, a consequence of the
up-regulation of AT1 receptors, likely down-regulation of AT2 receptors
in the vascular system.
Interestingly, animals subjected to a high salt diet showed a more
pronounced hyperresponsiveness to angiotensin I compared with an-
giotensin II (Figs. 1 and 3). Angiotensin I is converted to angiotensin II
by ACE. Indeed, the pressor effects observed after the administration
of angiotensin I are induced by angiotensin II. Therefore, we investigat-
ed if the augmented reactivity to angiotensin I in animals from the high
salt groups might involve changes in the activity of ACE. The results re-
vealed that the activity of ACEwas signiﬁcantly increased in the plasma
of animals subjected to 8%NaCl in their chow, while it was not impaired
in animals fedwith 2 and 4%NaCl chow (Fig. 2a). The activity of ACE has
been widely investigated in animals subjected to different levels of salt
intake and is generally acceptable that low sodium consumption can upregulate its activity [12]. On the other hand, usingWistar-Kyoto rats fed
with chow containing 8% NaCl for 21 days Ingert and co-workers found
a similar increase in both plasma and renal ACE activity, accompanied
by increased angiotensinogen levels and reduced renin activity [20].
Although we have not been able to measure the plasma levels of
angiotensinogen and renin in our experiments, a reduction in plasma
Fig. 4. Systolic arterial pressure of conscious rats exposed to high-sodium intake for six
weeks. The results shown aremean ± SEM (n = 16). Statistical analyseswere performed
by two-way analysis of variance followed by Bonferroni's post hoc test. No statistically sig-
niﬁcant differences were found.
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previous studies [23]. Taken together with our data, these studies
suggest that the reduced levels of angiotensin II found in the plasma
of healthy rats exposed to a high salt diet result from a decreased avail-
ability of angiotensin I, rather than from a deﬁcit in the ability of ACE to
catalyze the conversion of angiotensin I to angiotensin II, since plasma
ACE activity is maintained or increased in these animals (Fig. 2). Im-
portantly, our study suggests that in animals subjected to very high
amounts of sodium (8% NaCl group) during six weeks, the increased
activity of ACE contributes to avoid an even greater reduction in plasma
levels of angiotensin II.Fig. 5. Reduced plasma levels of angiotensin II and aldosterone in normotensive rats ex-
posed to a high-sodium diet for six weeks. Angiotensin II (a) and aldosterone (b) were
measured in plasma collected from rats exposed to regular chow (control) or high NaCl
(4 and 8%) chow. The results shown are mean ± SEM (n = 5–7). Statistical analyses
were performed by one-way analysis of variance followed by Bonferroni's post hoc test.
*P b 0.05 compared with the control group.
Fig. 6. Increased diuresis and natriuresis in normotensive rats exposed to a high-sodium
diet for sixweeks. Urinary volume (a) and amount of sodiumexcreted (b) by rats exposed
to control or high salt diet for six weeks. The results shown are mean ± SEM (n = 5–8).
Statistical analyses were performed by two-way analysis of variance followed by
Bonferroni's post hoc test. *P b 0.05 compared with the control group.We also demonstrated that the duration of the hypotensive effect of
bradykinin, an endogenous vasodilator that is inactivated by ACE, was
signiﬁcantly reduced in rats from the 8%NaCl group (Fig. 2b), conﬁrming
the biological relevance of the augmented plasma ACE activity found in
this group. Bradykinin, acting as an endogenous agonist of constitutive
bradykinin B2 receptors in endothelial cells, is well known by its ability
to stimulate the production of endothelium-derived relaxing factors
[38], such as nitric oxide [5,14], prostacyclin [43], and endothelium-
derived hyperpolarizing factor [11,28]. Moreover, activation of bradyki-
nin B2 receptors have been implicated in the production of nitric oxide
mediated by stimulation of AT2 receptors in different tissues, including
kidneys [1] and uterine artery [15], among others [3]. Thus, the increased
activity of ACE explains the reduced duration of the hypotension in-
duced by exogenous bradykinin in 8% NaCl groups. In addition, taken
into account the physiological roles of bradykinin in the vascular sys-
tem, this ﬁnding suggests that a decreased bioavailability of endoge-
nous bradykinin mediated by ACE may contribute to reduce the
release of endothelium-derived relaxing factors in animals subjected
to the high salt diet, which in turn may explain, at least in part, the
increased duration of the pressor effect of angiotensin II found in our
study.
Epidemiological studies have shown a correlation between exces-
sive dietary salt intake and increased prevalence and incidence of es-
sential hypertension [10]. Nonetheless, after being on a high salt diet
for six weeks, none of the animals in the current study showed hyper-
tension, even when arterial pressure was assessed in conscious animals
(Fig. 4). Unlike measurements performed in anesthetized rats, assess-
ment of arterial pressure in conscious animals retains all the effects of
salt on the central nervous system, including the previously described
sympathoexcitatory action associated with salt-induced hypertension
in salt-sensitive subjects [8,17,18]. Interestingly, high salt-induced
Fig. 7. Impaired expression and functionality of angiotensin II type1 (AT1) and type 2 (AT2) receptors in the aorta of normotensive rats exposed to a high-sodiumdiet for sixweeks. Protein
expression of AT1 (a) and AT2 (b) receptors in the aorta of the control and 4% NaCl groups was measured by Western blotting. The values were normalized by β-actin expression and
shown in arbitrary units. Reduced inhibition of the pressor effects of angiotensin II (c) and diminished hypotensive effects (d) induced by losartan in NaCl groups. The results shown
are mean ± SEM of ﬁve samples, obtained from different rats (a and b), or ﬁve-six animals per group (c). Statistical analyses were performed by Student's t test (a and b) or two-way
analysis of variance followed by Bonferroni's post hoc test (c and d). *P b 0.05 compared with the control group.
73S. Crestani et al. / Vascular Pharmacology 60 (2014) 67–74hypertension can be easily achieved by combining sodium overload
with mineralocorticoid stimulation (by deoxycorticosterone acetate)
[21,39], or angiotensin II administration [26], but it is rarely described
in normotensive rats. Our experiments were performed in healthy rats
(not salt-sensitive, previously hypertensive, or treatedwithmineralocor-
ticoids or angiotensin II). The exposure of these animals to a high salt diet
resulted in an intense natriuresis accompanied by elevated urine ﬂow
(Fig. 6), with no change in plasma sodium (data not shown), which
may explain the lack of hypertension in healthy rats, as previously dem-
onstrated [29]. Importantly, even in the absence of hypertension, exces-
sive consumption of sodium has been associatedwith deleterious effects
on the cardiovascular system, such as ﬁbrosis in the left ventricle and
intramyocardial vessels, and left ventricular and renal hypertrophy
[44,45]. Interestingly, in normotensive mice, high salt-induced cardiac
hypertrophy and interstitial ﬁbrosis were avoided when AT1 receptors
or ACEwere pharmacologically inhibited [27]. Our data showing an aug-
mented sensitivity of the cardiovascular system to angiotensin II, as well
as the reduced hypotensive effect of the AT1 receptor antagonist
losartan, help us to understand the efﬁcacy of AT1 receptor antagonists
and ACE inhibitors against the deleterious effects associated with high
salt intake, since they reveal that, regardless of the reduced amounts of
plasma angiotensin II found in these animals and themaintenance of sys-
temic arterial pressure at normal values, the cardiovascular system
remains fully responsive to angiotensin II.
Activation of angiotensin II AT1 receptors was previously associated
with superoxide production, amechanism thatmay contributewith the
development of hypertension [35]. Interestingly, vessels isolated from
both Sprague–Dawley rats fed for 3 days with 4% NaCl chow [47] and
C57BL/6J mice fed a 7% NaCl chow for 4 weeks [31] displayed reduced
nitric oxide production and increased superoxide generation, that was
mediated at least in part by uncoupled endothelial nitric oxide synthase
[32], and was enhanced in endothelial nitric oxide synthase knockout
mice [25]. In our study we found reduced plasma levels of nitric oxide
metabolites (nitrite/nitrate, as measured by Griess reaction) in rats fedwith 8% NaCl chow (data not show). Although we have not explored
the involvement of superoxide and nitric oxide production in our ﬁnd-
ings, it is reasonable considering that an unbalanced production of
these mediators after the continuous high salt intake would reduce
the inﬂuence of basal and stimulated nitric oxide against vasoconstric-
tor events, contributing to the increasing peak and duration of the pres-
sor effects of angiotensin II described in this study. Nevertheless, based
in the results obtained in both anesthetized and conscious rats, these
changes were not enough to induce hypertension in healthy rats even
after a period of six weeks under high salt intake, although deleterious
changes in vascular function and structure, which may precede the de-
velopment of hypertensive states, cannot be discarded. The role of AT1
receptors, NADPH-oxidase, superoxide generation and oxidative stress
for the vascular function of animals subjected for high salt intake
deserves further investigation.
5. Conclusions
In summary, despite the ﬁnding that RAAS appears to be less active
in healthy rats (neither salt-sensitive nor hypertensive) subjected to
high salt intake, as demonstrated by reduced plasma levels of both
angiotensin II and aldosterone, our data, obtained in vivo after 6 weeks
of high salt ingestion, suggest that the systemic ability of ACE to convert
angiotensin I to angiotensin II is maintained or even increased in healthy
rats subjected to high amounts of sodium. This is demonstrated by the
enhanced pressor effects induced by intravenous administration of an-
giotensin I, the physiological precursor of angiotensin II, aswell as the re-
duced effects of bradykinin, an endogenous vasodilator able to stimulate
nitric oxide production in endothelial cells. This study also shows that
the increased ability of the cardiovascular system to convert angiotensin
I to angiotensin II is associatedwith enhanced effects of angiotensin II on
arterial pressure. This may explain why rodents usually do not display
hypotension, in spite of reduced plasma levels of both angiotensin II
and aldosterone. On the other hand, the enhanced sensitivity to
74 S. Crestani et al. / Vascular Pharmacology 60 (2014) 67–74angiotensin II that is mediated, at least in part, by increased expression
of AT1 receptors and reduced expression of AT2 receptors, may render
the entire cardiovascular system susceptible to the deleterious effects
mediated by angiotensin II. Importantly, the reduced effects of losartan
in rats fed high salt diet indicates that the up-regulation of AT1 recep-
tors in the vascular system contributes to the maintenance of the regu-
latory effects of endogenous angiotensin II on the arterial pressure of
these animals, and may play a role in the vascular dysfunction associat-
ed with high salt intake in normotensive animals. If extrapolated to
humans, our study emphasizes the potential involvement of the
renin–angiotensin–aldosterone system in the risks associated with
high salt consumption, even in the absence of systemic hypertension.
The systemic, local and cellular consequences involved in this process
deserve further investigation.
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